Proellex Pharmacokinetics Bridging Study

Completed · Phase 1

Conditions studied: Healthy

In brief

Healthy female subjects received a single dose of four different types of Proellex, the original 25 mg dose and three new formulations

Key facts

Study ID

NCT01067807

Run by

Repros Therapeutics Inc.

People needed

21

Starts

2007-06-01

Expected to finish

2007-07-01

Last updated by the study team

2014-07-08

Who can join

Age: 18 and older, up to 40. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Medically normal subjects with no significant abnormal findings at the screening physical examination as evaluated by the clinical Investigator
• Subject was willing to remain in the clinic for the screening visit; and for the treatment visits (day -1, day of treatment and day 1; approximately 36 hrs per treatment visit)

You may not qualify if…

• Post-menopausal women,
• Subject with documented endometriosis
• Subject with known uterine fibroids or vaginal polyps

Where it is running

• Healthcare Discoveries, Inc — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.